Live News Coverage from ASH: As you know, I am a... - CLL Support

CLL Support

22,512 members38,664 posts

Live News Coverage from ASH

andrewschorr profile image
0 Replies

As you know, I am a newsman at heart - a journalist since 1967 as a student. Since 1984 I have devoted myself to bringing news to patients with serious illnesses and it has become clear patients want news that can improve their care faster and hear it, if possible, directly from world experts - unfiltered. So, in many conditions, as the pace of medical progress has accelerated, it has become apparent to me it makes sense to cover the news LIVE on video at the medical conventions where news breaks. In a few days there's a big medical convention in Orlando, with about 30,000 researchers and physicians who deal with blood cancers in attendance. I have two of those conditions (chronic lymphocytic leukemia and myelofibrosis - but, because of past progress, doing well!). So this year Patient Power will extensively broadcast live interviews, updates and "ask the expert" sessions right from the convention, and where patients around the world can ask questions via email, text and on their webcams. It will be true interactive online television for patients and family members. All someone needs to do to be hooked in is to join the patient power community for their health condition. See:

patientpower.info/video/liv...

The service is free and I am excited about it. Please tune in if this is helpful to you or someone you care about. This is does a medical journalist's heart good :)

Written by
andrewschorr profile image
andrewschorr
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Reporting from ASCO 2019 (yes ASCO, not ASH)

Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic...

News from iwCLL, what it means for you

weekend CLL experts from around the world will meet to compare notes. A week later, Sat. 9/28,...

Breaking news form ASH conference: looks like Ibrutinib May be better than FCR for some patients

(FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL) |...

Good news from my consultant !

fantastic news for me (and my wife) . I am quite happy never to go shopping ever again and can live...

ASH 2018: ECOG trial shows superiority of Ibrutinib and rituximab over FCR

to FCR for both overall and progression free survival for frontline patients <70 years old.. For...